Therefore, we examined whether VEGF-C is involved in LNMAT1-induced lymphangiogenesis and whether LNMAT1-induced CCL2 excretion by bladder cancer cells could induce VEGF-C expression in TAMs. The gene discussed is DUXAP9; the disease is urinary bladder carcinoma.